Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.
Br J Ophthalmol. 2021 Nov;105(11):1515-1519. doi: 10.1136/bjophthalmol-2020-317354. Epub 2020 Sep 15.
To establish expert recommendations for the management of ocular sarcoidosis (OS).
A question-based survey on the management of OS was circulated to international uveitis experts (members of the International Uveitis Study Group and the International Ocular Inflammation Society) electronically. Subsequently, a consensus workshop was conducted at the 7th International Workshop on Ocular Sarcoidosis (IWOS) in June 2019 in Sapporo, Japan as part of the Global Ocular Inflammation Workshops. Statements on the management of OS that were supported by a two-thirds majority of 10 international panel members of the workshop, after discussion and voting, were taken as consensus agreement.
A total of 98 participants from 29 countries responded to the questionnaire survey. The subsequent consensus workshop established recommendations for the management of OS in five sections. The first section concerned evaluation and monitoring of inflammation. The second, third and fourth sections described ocular manifestations that were indications for treatment, and the management of anterior uveitis, intermediate uveitis and posterior uveitis. In the fifth section, the use of systemic corticosteroids and systemic immunosuppressive drugs were detailed.
Recommendations for management of OS were formulated through an IWOS consensus workshop.
制定眼结节病(OS)管理的专家建议。
通过电子邮件向国际葡萄膜炎专家(国际葡萄膜炎研究组和国际眼内炎症学会的成员)发送了一项基于问题的 OS 管理调查。随后,作为全球眼内炎症研讨会的一部分,于 2019 年 6 月在日本札幌举行了第 7 届眼结节病国际研讨会(IWOS)的共识研讨会。在讨论和投票后,得到研讨会的 10 名国际小组成员中三分之二多数支持的 OS 管理声明被视为共识协议。
共有来自 29 个国家的 98 名参与者对问卷调查做出了回应。随后的共识研讨会在五个部分中确定了 OS 管理建议。第一部分涉及炎症的评估和监测。第二、第三和第四部分描述了治疗指征的眼部表现,以及前葡萄膜炎、中间葡萄膜炎和后葡萄膜炎的治疗。在第五部分中,详细介绍了全身皮质类固醇和全身免疫抑制剂的使用。
通过 IWOS 共识研讨会制定了 OS 管理建议。